Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × palbociclib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 96 Neoplasms 11 Neoplasm Metastasis 8 Sarcoma 6 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Melanoma 5 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Multiple Myeloma 3 Liposarcoma 3 Glioblastoma 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Breast Diseases 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasm, Residual 2 Lymphoma, Non-Hodgkin 2 Inflammation 2 Head and Neck Neoplasms 2 Estrogen Receptor-positive Breast Cancer 2 Esophageal Squamous Cell Carcinoma 2 Chordoma 2

Interventions

Sunitinib 23 Everolimus 17 aldesleukin 16 Sorafenib 16 Bevacizumab 16 Nivolumab 15 Peripheral Blood Stem Cell Transplantation 13 pembrolizumab 12 fludarabine phosphate 12 Interleukin-2 12 Interferon-alpha 12 Cyclophosphamide 12 Radiotherapy 11 Blood Specimen Collection 11 Radiosurgery 10 Ipilimumab 10 Gemcitabine 10 Filgrastim 9 Axitinib 9 Gene Expression Profiling 7 temsirolimus 6 Surveys and Questionnaires 6 Surgical Procedures, Operative 6 Cryosurgery 6 pazopanib 5 durvalumab 5 cabozantinib 5 Mycophenolic Acid 5 Immunohistochemistry 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07123090 2026-02-27

SPARCC

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡